LIBERATE trial: sustained efficacy of apremilast in patients with moderate-to-severe psoriasis who continued on apremilast or switched from etanercept treatment

被引：0
|
作者：
Reich, K. [1 ]
Soung, J. [2 ]
Gooderham, M. [3 ]
Zhang, Z. [4 ]
Nograles, K. [4 ]
Goodfield, M. [5 ]
机构：
[1] SCIderm Res Inst & Dermatologikum Hamburg, Hamburg, Germany
[2] Southern Calif Dermatol, Santa Ana, CA USA
[3] SKiN Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada
[4] Celgene Corp, Summit, NJ USA
[5] Leeds Gen Infirm, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P103
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [1] Sustained efficacy of apremilast in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the LIBERATE study
    Reich, Kristian
    Soung, Jennifer
    Gooderham, Melinda
    Zhang, Zuoshun
    Nograles, Kristine
    Goodfield, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB276 - AB276
  • [2] Efficacy of apremilast sustained through week 52 in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: results from the liberate study
    Reich, K.
    Papp, K.
    van de Kerkhof, P.
    Zhang, Z.
    Nograles, K.
    Soung, J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 68 - 68
  • [3] SAFETY AND EFFICACY OF APREMILAST THROUGH 104 WEEKS IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS WHO CONTINUED ON APREMILAST OR SWITCHED FROM ETANERCEPT TREATMENT IN THE LIBERATE STUDY
    Reich, K.
    Goodfield, M.
    Green, L.
    Nograles, K.
    Chen, R.
    Levi, E.
    Langley, R. G. B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1325 - 1326
  • [4] Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment in the LIBERATE study
    Reich, Kristian
    Goodfield, Mark
    Green, Lawrence
    Nograles, Kristine
    Chen, Rongdean
    Levi, Eugenia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB224 - AB224
  • [5] Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study
    Reich, K.
    Gooderham, M.
    Bewley, A.
    Green, L.
    Soung, J.
    Petric, R.
    Marcsisin, J.
    Cirulli, J.
    Chen, R.
    Piguet, V.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 397 - 402
  • [6] 52-Week efficacy in patients with moderate to severe psoriasis continued on apremilast or switched from etanercept: The LIBERATE study
    Reich, K.
    Papp, K.
    van de Kerkhof, P.
    Zhang, Z.
    Nograles, K.
    Soung, J.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 69 - 70
  • [7] Sustained efficacy with apremilast in patients with nail and scalp psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the LIBERATE study
    Gooderham, Melinda
    Zhang, Zuoshun
    Day, Robert
    Ferris, Laura
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB277 - AB277
  • [8] Sustained efficacy with apremilast in patients with nail and scalp psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the liberate study
    Gooderham, M.
    Zhang, Z.
    Day, R.
    Ferris, L.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 66 - 67
  • [9] Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or Apremilast
    Natsis, Nicola E.
    Merola, Joseph F.
    Weinberg, Jeffrey M.
    Wu, Jashin J.
    Orbai, Ana-Maria
    Bagel, Jerry
    Gottlieb, Alice B.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (01) : 109 - 117
  • [10] Cost per responder of apremilast and etanercept in patients with moderate to severe plaque psoriasis using results from LIBERATE
    Tencer, Tom
    Clancy, Zoe
    Zhang, Frank
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB242 - AB242
12345